Oct 14, 2021 10:38 AM (GMT+8)
Financial Associated Press, October 14 (Xinhua) - Shanghai Sunshine pharmaceutical procurement network issued a notice on the fifth batch of work related to the centralized procurement and use of drugs organized by the state. The notice pointed out that we should take into account the stability of drug supply and clinical medication, do not engage in centralized procurement of selected drugs, and do not adopt the "one size fits all" approach of cutting off and stopping drugs for non selected drugs, which is the same as the common name (including dosage form) in principle The proportion of drugs not selected shall be maintained at about 20%. If the original municipal winning drugs (or network drugs) with the same common name (including dosage form) as the winning drugs do not obtain the winning qualification, but the quality and curative effect are guaranteed and the price is appropriate, the medical institution can continue to purchase the winning drugs on the premise of giving priority to the purchasing of the winning drugs. In principle, the quantity shall not exceed the winning drugs. In case of untimely supply and distribution of the selected products, the purchase quantity limit of the non selected drugs shall be released periodically as appropriate. If the original drug that has not been selected and the generic drug enterprise that has passed the consistency evaluation actively reduces the price below the selected price in the city (including the selected price), after the agreed purchase quantity of the corresponding selected drug is completed, the non selected drug will not be affected by the restriction of priority purchase and relevant assessment.
This text is a result of machine translation.